Antibody mimetic
Antibody mimetics are organic compounds that, like
kDa
. (Antibodies are ~150 kDa.)
Nucleic acids and small molecules are sometimes considered antibody mimetics as well, but not artificial antibodies, antibody fragments and fusion proteins composed from these.
Common advantages over antibodies are better
therapeutic and diagnostic agents.[1]
Examples
Antibody mimetic | Scaffold | Molar mass | Example drug |
---|---|---|---|
Affibody molecules[2] | Z domain of Protein A | 6 kDa | ABY-025 |
Affilins[3] | Gamma-B crystallin |
20 kDa | |
Ubiquitin | 10 kDa | SPVF 2801 | |
Affimers[4] (Adhirons)
|
Cystatin | 12–14 kDa | |
Affitins[5] | Sac7d (from Sulfolobus acidocaldarius) | 7 kDa | |
Alphabodies[6] | Triple helix coiled coil | 10 kDa | CMPX-1023 |
Anticalins[7] | Lipocalins | 20 kDa | |
Avimers[8] | A domains of various membrane receptors | 9–18 kDa | |
DARPins[9] | Ankyrin repeat motif | 10–19 kDa | MP0112 |
Fynomers[10] | SH3 domain of Fyn | 7 kDa | |
Gastrobodies[11] | Kunitz-type soybean trypsin inhibitor | 20 kDa | |
Kunitz domain peptides[12] |
Kunitz domains of various protease inhibitors | 6 kDa | Ecallantide (Kalbitor) |
Monobodies[13] | 10th type III domain of fibronectin | 10 kDa | Pegdinetanib (Angiocept) |
nanoCLAMPs[14] | Carbohydrate Binding Module 32-2 (from Clostridium perfringens NagH) | 16 kDa | |
Optimers[15] | Flexible nucleic acid based scaffold; G-quadruplex | 8-15 kDa | |
Repebodies[16] | leucine-rich repeats | ||
Pronectin™[17] | fourteenth fibronectin type-III scaffold of Human Fibronectin (14Fn3) | 10 kDa | |
Centyrins[18] | highly stable fibronectin type III (FN3) domain | 10 kDa | |
Obodies[19] | a high affinity binding protein domain engineered to bind to Hen Egg-white Lysozyme |
See also
- Protein mimetic
- Optimer Ligand
References
- PMID 19501012.
- PMID 18435759.
- PMID 17628592.
- PMID 22789061.
- PMID 18822295.
- PMID 25354530.
- S2CID 19992238.
- S2CID 84757398.
- PMID 18621567.
- PMID 17130124.
- PMID 34381153.
- PMID 16566296.
- PMID 17041261.
- PMID 28428153.
- ^ "Rapid identification and development of SARS-CoV-2 selective Optimers". Aptamer Group. 11 December 2020. Retrieved 2021-08-03.
- PMID 29185244.
- ^ "Pronectin Technology". Protelica. Retrieved 2021-09-26.
- PMID 27737926.
- ^ Chonira VK (2018). Engineering and characterisation of anti-progesterone OBodies (Thesis thesis). The University of Waikato.